Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree? - Wikidata - awgldk - TriplyDB

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

http://www.wikidata.org/entity/Q39839514

about

Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.Patients' preferences for treatment of hepatitis C Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1 The hepatitis C cascade of care: identifying priorities to improve clinical outcomes Hepatitis C treatment experiences and decision making among patients living with HIV infection.The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients.Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.Clinical impact of treatment timing for chronic hepatitis C infection: a decision model Can urban methadone patients complete health utility assessments?Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection.Variations in Physician Attitudes Regarding ADHD and Their Association With Prescribing Practices Methods and issues associated with the use of quality-adjusted life-years.Patient preferences versus physicians' judgement: does it make a difference in healthcare decision making?Listening to both sides: A qualitative comparison between patients with hepatitis C and their healthcare professionals' perceptions of the facilitators and barriers to hepatitis C treatment adherence and completion.Listening to both sides: A qualitative comparison between patients with hepatitis C and their healthcare professionals' perceptions of the facilitators and barriers to hepatitis C treatment adherence and completion.Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.Patient preferences and assessment of likely adherence to hepatitis C virus treatment.

P2860

Q30870323-DBE2BCE5-B12C-40EE-A016-2EBA51B1AA44 Q33615461-4E6C181A-DE12-4774-8595-A318CC0DD29E Q33629561-4A32949B-15E1-4E70-8E13-1EB609AD1F93 Q33632459-C3ECD6EC-F95C-4A29-94D2-2EFCD4C78BD4 Q33636377-64AC3959-3494-44E3-8384-D9C9CD0C8F88 Q33710740-58C4BFCE-99E6-4EFF-97B5-AD41005AB416 Q34735072-0F641A6C-0331-4BC7-AED8-2651CB87C187 Q35572125-26EDE60C-8569-42F7-B84D-E47274043904 Q35889164-4E41EF84-2236-4196-B091-AF4A8D4BC696 Q36613778-540095A3-8084-4E35-B035-F31A93AA0F90 Q37021514-74AC6630-ABC5-4FAA-A2C2-125481336995 Q37714495-FC4A3767-9F3A-44BB-B067-030939F4EEE3 Q37978909-A85FAF44-83CB-4938-AE3C-8A2C03D8265F Q38093110-A1247260-C3AE-49F2-8E61-0A2E867AF3EE Q40561879-A742B9C8-13C0-4056-A5C1-C052072A5C8F Q40921653-44F2625B-20E8-4C63-ABDE-72AB9B6F6774 Q40929078-4C788F76-EF0B-43C2-85D1-028184239F54 Q41919051-152911CF-5335-4A35-9C3C-BEB42B2AB6D8 Q42998032-0CFB1090-DC9F-446B-BEAC-76C691B109BA

P2860

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

http://www.wikidata.org/entity/Q39839514

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

@en

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

@nl

type

label

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

@en

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

@nl

prefLabel

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

@en

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

@nl

P1433

Q39839514-13D08135-AF8D-4428-A509-6042B9AF5DE8

P1476

Q39839514-33F5F7D3-D138-4FEF-83B6-CF2831E1017A

P2093

Q39839514-60C858E0-CBC2-4B06-8E16-3EBBD9B736F5

Q39839514-69D01696-217B-4E95-8E65-08E9324330BA

Q39839514-AE7DBB2D-BED9-4174-A379-16122BB8D799

Q39839514-AF79E097-8F1A-4862-9055-2E21113E8660

Q39839514-FE37840F-1B1A-49A5-9EE3-4921E4C69F66

P2860

Q39839514-057B0FD2-9EEB-48FB-A10E-D756BCB93EB4

Q39839514-13FD88DF-5AA4-422C-B07C-58E976AB5985

Q39839514-16D3AF38-6BB0-42B5-BAE7-61B93697B2B9

Q39839514-18DBE7EF-EA10-41E8-BCE4-316C48CE9354

Q39839514-19A6B694-5A4D-4902-91BF-B2B824F3AE24

Q39839514-209AD220-9A22-462C-A183-8CE4C557422D

Q39839514-2100B1E8-B118-42F9-A03A-424164C24A2D

Q39839514-24AC6B6A-5E41-4113-871A-124493EF2731

Q39839514-27DECEB2-C3C5-4B92-BB34-40F110719E8F

Q39839514-304F924D-DDD2-4278-8FE9-DFB4075811FA

P304

Q39839514-021B2488-CBD7-4EFB-820B-B5BCDB8B36B4

P31

Q39839514-6F46A791-5CC7-44AE-AEF8-8A2F97F76A8E

P356

Q39839514-341A6A88-94A3-4BCC-9A6D-497EE968077C

P433

Q39839514-DFD66AA1-2002-4D61-8F67-5980562EBD0E

P478

Q39839514-0FF593BC-B4B3-47D1-BE37-F3E43E17A1E4

P577

Q39839514-097D1B24-46B1-4616-884D-74A746C1661E

P5875

Q39839514-EB7C9BB5-E500-45D6-B713-DCD4B728E7AC

P698

Q39839514-615CB5F3-CAEE-4080-A001-82B3E0CAC9DD

P921

Q39839514-EA80CD3F-68AC-41E2-A5E7-FE48FA3289F2

P356

0272989X07311753

P1433

Medical Decision Making

P1476

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

@en

P2093

Alvin I Mushlin

http://www.w3.org/2001/XMLSchema#string

Bruce R Schackman

http://www.w3.org/2001/XMLSchema#string

Gil Weitzman

http://www.w3.org/2001/XMLSchema#string

Ira M Jacobson

http://www.w3.org/2001/XMLSchema#string

Paul A Teixeira

http://www.w3.org/2001/XMLSchema#string

P2860

Physicians' preference values for hepatitis C health states and antiviral therapy: a survey

Hepatitis C in the HIV-Infected Person

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Patient preferences for adjuvant interferon alfa-2b treatment.

Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.

Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity.

The impact of diagnosis of hepatitis C virus on quality of life.

P304

233-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0272989X07311753

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5503903

http://www.w3.org/2001/XMLSchema#string

P698

18349430

http://www.w3.org/2001/XMLSchema#string

P921

quality of life